(Q46661788)

24 December 2017

title

Optimization of mobile phase for the determination of Esomeprazole and related compounds and investigation of stress degradation by LC-MS. (English)

1 reference

24 December 2017

1 reference

Qixin Dong

1

1 reference

24 December 2017

Jiajun Zhu

2

1 reference

24 December 2017

Qiang Sui

3

1 reference

24 December 2017

Chao Tang

4

1 reference

24 December 2017

Xiaomei Wang

5

1 reference

24 December 2017

Yunqiu Yu

6

1 reference

24 December 2017

publication date

11 March 2013

1 reference

24 December 2017

Journal of Separation Science

published in

1 reference

24 December 2017

volume

36

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

1200-1208

1 reference

24 December 2017

describes a project that uses

liquid chromatography–mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Direct HPLC enantioseparation of omeprazole and its chiral impurities: application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Retention of ionisable compounds on high-performance liquid chromatography. XV. Estimation of the pH variation of aqueous buffers with the change of the acetonitrile fraction of the mobile phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Degradation of lansoprazole and omeprazole in the aquatic environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Omeprazole: the first proton pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

Asymmetric synthesis of esomeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJSSC.201201114

21 January 2018

Identifiers

DOI

10.1002/JSSC.201201114

1 reference

24 December 2017

1 reference

24 December 2017